Canaccord Genuity Reaffirms Their Buy Rating on Niagen Bioscience (NAGE)
Canaccord Genuity's Susan Anderson reaffirms a Buy rating on Niagen Bioscience (NAGE) with a $14.00 price target. Anderson, a 5-star analyst with a 16.5% average return, covers the Consumer Cyclical sector. The Street consensus rates Niagen Bioscience as a Strong Buy with a $16.33 average price target.
In a report released today, Susan Anderson from Canaccord Genuity maintained a Buy rating on Niagen Bioscience, with a price target of $14.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, Anderson is a 5-star analyst with an average return of 16.5% and a 44.42% success rate. Anderson covers the Consumer Cyclical sector, focusing on stocks such as Ulta Beauty, Sally Beauty, and Peloton Interactive.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Niagen Bioscience with a $16.33 average price target.
